Danahervs.Thermo Fisher Scientific
DHR vs TMO · both in Life science tools, part of the Medicine, pharma & life science value chain: Instruments, reagents and equipment for research, development and production.
Thermo Fisher Scientific is about 1.4× larger than Danaher by market cap; Thermo Fisher Scientific trades at the lower P/E (28.6 vs 38.1); year to date, Thermo Fisher Scientific leads (−9.0% vs −13.0%).
Side by side
| DHR | TMO | |
|---|---|---|
| Market cap | $141B | $196B |
| Price | $199.05 | $527.05 |
| Today | +1.6% | +0.4% |
| Return YTD | −13.0% | −9.0% |
| Return 1Y | −3.1% | +22.4% |
| P/E | 38.1 | 28.6 |
| P/S | 5.7 | 4.3 |
| P/B | 2.7 | 3.8 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
DanaherDHR
American group focused on life science and diagnostics — bioprocessing (Cytiva), molecular diagnostics and laboratory solutions.
Full DHR profile →Thermo Fisher ScientificTMO
American world leader in life science tools — instruments, reagents, consumables and contract manufacturing (Patheon) for research and pharma.
Full TMO profile →More comparisons in Life science tools
See where DHR and TMO sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →